AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -72.7% | 47,814 | -26.9% | 0.00% | – |
| Q2 2022 | $11,000 | -60.7% | 65,373 | +10.0% | 0.00% | – |
| Q1 2022 | $28,000 | -76.3% | 59,425 | -71.0% | 0.00% | – |
| Q4 2021 | $118,000 | -46.4% | 204,990 | +54.4% | 0.00% | – |
| Q3 2021 | $220,000 | -32.7% | 132,799 | -32.3% | 0.00% | – |
| Q2 2021 | $327,000 | -39.7% | 196,077 | -38.9% | 0.00% | – |
| Q1 2021 | $542,000 | +2752.6% | 320,964 | +2517.1% | 0.00% | – |
| Q4 2020 | $19,000 | -90.1% | 12,264 | -97.5% | 0.00% | – |
| Q2 2019 | $191,000 | +607.4% | 494,402 | +902.8% | 0.00% | – |
| Q1 2019 | $27,000 | -12.9% | 49,301 | -35.7% | 0.00% | – |
| Q4 2018 | $31,000 | -32.6% | 76,707 | -14.3% | 0.00% | – |
| Q3 2018 | $46,000 | -2.1% | 89,499 | +319.8% | 0.00% | – |
| Q2 2018 | $47,000 | -95.1% | 21,321 | -92.4% | 0.00% | – |
| Q1 2018 | $950,000 | +541.9% | 279,467 | -1.4% | 0.00% | – |
| Q2 2017 | $148,000 | +770.6% | 283,490 | +1260.8% | 0.00% | – |
| Q1 2017 | $17,000 | +88.9% | 20,832 | +66.9% | 0.00% | – |
| Q3 2016 | $9,000 | -35.7% | 12,482 | +16.4% | 0.00% | – |
| Q2 2016 | $14,000 | -82.5% | 10,725 | -53.2% | 0.00% | – |
| Q4 2015 | $80,000 | -75.4% | 22,905 | -79.6% | 0.00% | – |
| Q3 2015 | $325,000 | -24.6% | 112,302 | -38.3% | 0.00% | – |
| Q2 2015 | $431,000 | -36.4% | 181,928 | +101.9% | 0.00% | – |
| Q1 2015 | $678,000 | +264.5% | 90,114 | +66.5% | 0.00% | – |
| Q4 2014 | $186,000 | -21.5% | 54,114 | +45.0% | 0.00% | – |
| Q1 2014 | $237,000 | -16.3% | 37,312 | -6.2% | 0.00% | – |
| Q4 2013 | $283,000 | -66.8% | 39,760 | -65.0% | 0.00% | – |
| Q3 2013 | $853,000 | +81.5% | 113,700 | +39.5% | 0.00% | – |
| Q2 2013 | $470,000 | +993.0% | 81,495 | +580.9% | 0.00% | – |
| Q4 2012 | $43,000 | +2.4% | 11,969 | +12.2% | 0.00% | – |
| Q3 2012 | $42,000 | -90.3% | 10,672 | -87.5% | 0.00% | – |
| Q2 2012 | $433,000 | – | 85,185 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|